Construction and validation of a prognostic prediction model based on albumin-bilirubin grade after resection of hepatocellular carcinoma

doi:10.4240/wjgs.122279

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 11

This Article

(2)

(0)

(82)

Peer-Review Report of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Gastrointest Surg. Nov 27, 2026; 18(11): 122279
Published online Nov 27, 2026. doi: 10.4240/wjgs.122279

Full Size Figure Download Figure

Figure 4 Calibration curves for predicting recurrence-free survival. A: Training set for 1- and 2-year recurrence-free survival; B: Validation set for 1- and 2-year recurrence-free survival. RFS: Recurrence-free survival.

Citation: Cong LY, Ma LY, Hong X, Geng GL, Fan BF. Construction and validation of a prognostic prediction model based on albumin-bilirubin grade after resection of hepatocellular carcinoma. World J Gastrointest Surg 2026; 18(11): 122279
URL: https://www.wjgnet.com/1948-9366/full/v18/i11/122279.htm
DOI: https://dx.doi.org/10.4240/wjgs.122279

Cong LY, Ma LY, Hong X, Geng GL, Fan BF. Construction and validation of a prognostic prediction model based on albumin-bilirubin grade after resection of hepatocellular carcinoma. World J Gastrointest Surg 2026; 18(11): 122279 [DOI: 10.4240/wjgs.122279]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.